181 related articles for article (PubMed ID: 11893039)
1. Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas.
Jorda M; De MB; Nadji M
Appl Immunohistochem Mol Morphol; 2002 Mar; 10(1):67-70. PubMed ID: 11893039
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of A103 and inhibin-alpha in adrenocortical tumors: an immunohistochemical study using tissue microarray techniques].
Zhang HY; Wang XJ; Liu WP; Jiang LL; Li GD; Guo J; Zhang YH
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):203-7. PubMed ID: 15256108
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immunohistochemical markers in the differential diagnosis of adrenocortical tumors: immunohistochemical analysis of adrenocortical tumors.
Zhang H; Bu H; Chen H; Wei B; Liu W; Guo J; Li F; Liao D; Tang Y; Zhang Z
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):32-9. PubMed ID: 18091323
[TBL] [Abstract][Full Text] [Related]
4. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
[TBL] [Abstract][Full Text] [Related]
5. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
Sangoi AR; McKenney JK
Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic role of inhibin α-subunit and inhibin/activin β-subunit in adrenal cortical and medullary tumors in Egyptian patients.
Elmoneim HM; Samaka RM; Ali H
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):462-9. PubMed ID: 22417854
[TBL] [Abstract][Full Text] [Related]
7. Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis.
Salmenkivi K; Arola J; Voutilainen R; Ilvesmäki V; Haglund C; Kahri AI; Heikkilä P; Liu J
J Clin Endocrinol Metab; 2001 May; 86(5):2231-5. PubMed ID: 11344232
[TBL] [Abstract][Full Text] [Related]
8. [The expression of A103 and inhibin alpha in adrenocortical adenoma by high-throughput tissue microarray techniques].
Zhang H; Liu W; Wang X; Li G; Guo J; Li F; Liao D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):424-6. PubMed ID: 12910679
[TBL] [Abstract][Full Text] [Related]
9. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
[TBL] [Abstract][Full Text] [Related]
10. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.
Arola J; Liu J; Heikkilä P; Ilvesmäki V; Salmenkivi K; Voutilainen R; Kahri AI
J Endocrinol; 2000 May; 165(2):223-9. PubMed ID: 10810286
[TBL] [Abstract][Full Text] [Related]
11. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases.
Movahedi-Lankarani S; Kurman RJ
Am J Surg Pathol; 2002 Nov; 26(11):1477-83. PubMed ID: 12409724
[TBL] [Abstract][Full Text] [Related]
12. Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin.
Deavers MT; Malpica A; Ordonez NG; Silva EG
Int J Gynecol Pathol; 2003 Apr; 22(2):162-7. PubMed ID: 12649671
[TBL] [Abstract][Full Text] [Related]
13. Comparison of immunomarkers for the identification of adrenocortical cells in cytology specimens.
Jalali M; Krishnamurthy S
Diagn Cytopathol; 2005 Aug; 33(2):78-82. PubMed ID: 16007649
[TBL] [Abstract][Full Text] [Related]
14. [The expression and significance of chromogranin A and synaptophysin in adrenal gland tumors].
Feng C; Li HZ; Yan WG; Luo YF; Cao JL
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):486-8. PubMed ID: 16188147
[TBL] [Abstract][Full Text] [Related]
15. Expression of inhibin alpha in the human adrenal gland and adrenocortical tumors.
Arola J; Liu J; Heikkilä P; Voutilainen R; Kahri A
Endocr Res; 1998; 24(3-4):865-7. PubMed ID: 9888589
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
[TBL] [Abstract][Full Text] [Related]
17. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
18. Histologic and immunohistochemical classification of 41 bovine adrenal gland neoplasms.
Grossi AB; Leifsson PS; Jensen HE; Vainer B; Iburg T
Vet Pathol; 2013 May; 50(3):534-42. PubMed ID: 23242804
[TBL] [Abstract][Full Text] [Related]
19. Melan A (A103) is expressed in adrenocortical neoplasms but not in renal cell and hepatocellular carcinomas.
Ghorab Z; Jorda M; Ganjei P; Nadji M
Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):330-3. PubMed ID: 14663359
[TBL] [Abstract][Full Text] [Related]
20. Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms.
Shah VI; Freites ON; Maxwell P; McCluggage WG
J Clin Pathol; 2003 Mar; 56(3):221-4. PubMed ID: 12610103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
